文献速递母胎医学产科

胎儿骶尾部畸胎瘤生长速度预测围产期发病和死亡:多中心研究

Growth velocity of fetal sacrococcygeal teratoma as predictor of perinatal morbidity and mortality: multicenter study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

该多中心回顾性研究纳入2007年1月至2017年12月间在五个儿童外科和/或胎儿医学中心管理的55例孤立性骶尾部畸胎瘤胎儿,评估产前预测围产期不良结局的因素。31%(17例)出现围产期不良结局,肿瘤生长速度是唯一独立相关因素(每增加1 mm/周,OR 1.48,95%CI 1.22-1.97,P=0.001),最佳预测切点为7 mm/周(OR 25.7,95%CI 5.6-191.3,P<0.001),敏感度88%、特异度77%。

要点

  • 孤立性骶尾部畸胎瘤胎儿中31%出现围产期不良结局,总生存率75%。
  • 肿瘤生长速度是围产期不良结局的唯一独立预测因素(每增加1 mm/周,OR 1.48)。
  • 生长速度≥7 mm/周预测围产期不良结局的敏感度88%、特异度77%。

核心结论

  • 约30%的孤立性骶尾部畸胎瘤胎儿出现围产期不良结局。
  • 肿瘤生长速度≥7 mm/周似乎是预测围产期不良结局的合适判别切点。
  • 这些结果可能有助于为受累妊娠的产前管理和父母咨询提供信息。

研究设计与样本

  • 回顾性研究,纳入2007年1月至2017年12月间在五个儿童外科和/或胎儿医学中心管理的55例孤立性(非综合征性)骶尾部畸胎瘤胎儿。
  • 诊断时中位孕周为22周(四分位距18-23周)。
  • 主要结局为围产期不良结局,定义为产前死亡(包括终止妊娠)、新生儿死亡或严重并发症(失血性休克)。

主要发现

  • 31%(n=17)的病例出现围产期不良结局,包括宫内胎儿死亡4%(n=2)、终止妊娠13%(n=7)和新生儿严重并发症15%(n=8),其中5例导致新生儿死亡。
  • 产前诊断孤立性骶尾部畸胎瘤后的总生存率为75%(41/55)。
  • 单因素分析显示,诊断时孕周较早(P=0.02)、转诊时肿瘤体积大(P<0.001)、存在一个或多个血流动力学并发症(P=0.02)、肿瘤生长速度快(P<0.001)和高肿瘤分级(最高肿瘤分级≥3)(P=0.049)与围产期不良结局相关。
  • 逐步逻辑回归分析中,肿瘤生长速度是唯一剩余的与围产期不良结局独立相关的因素(每增加1 mm/周,OR 1.48,95%CI 1.22-1.97,P=0.001)。
  • 肿瘤生长速度预测围产期不良结局的最佳切点为7 mm/周(OR 25.7,95%CI 5.6-191.3,P<0.001),敏感度88%,特异度77%。

关键数值与推荐

  • 肿瘤生长速度≥7 mm/周预测围产期不良结局:敏感度88%,特异度77%,OR 25.7(95%CI 5.6-191.3),P<0.001。
  • 肿瘤生长速度每增加1 mm/周与围产期不良结局的OR为1.48(95%CI 1.22-1.97),P=0.001。
  • 围产期不良结局定义:产前死亡(包括终止妊娠)、新生儿死亡或严重并发症(失血性休克)。

临床怎么用

  • 作者认为肿瘤生长速度≥7 mm/周似乎是预测围产期不良结局的合适判别切点。
  • 作者认为这些结果可能有助于为受累妊娠的产前管理和父母咨询提供信息。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify prenatal predictors of poor perinatal outcome in fetuses with isolated sacrococcygeal teratoma (SCT). METHODS: This was a retrospective study of fetuses with isolated (non-syndromic) SCT managed at one of five pediatric surgery and/or fetal medicine centers between January 2007 and December 2017. The primary outcome was the occurrence of poor perinatal outcome, defined as prenatal death (including termination), or neonatal death or severe compromise (hemorrhagic shock). Data regarding prenatal diagnosis (sonographic features both at referral and at the last ultrasound examination before pregnancy outcome, assessment of SCT growth velocity), perinatal complications and outcome, and neonatal course were analyzed to determine prenatal SCT characteristics associated with adverse perinatal outcome. RESULTS: Fifty-five fetuses were included, diagnosed with isolated SCT at a median gestational age of 22 (interquartile range, 18-23) weeks. There was a poor perinatal outcome in 31% (n = 17) of these cases, including intrauterine fetal demise (4%, n = 2), pregnancy termination (13%, n = 7) and neonatal severe compromise (15%, n = 8), leading to neonatal death in five cases. The overall survival rate after prenatal diagnosis of isolated SCT was 75% (n = 41 of 55). Earlier gestational age at diagnosis (P = 0.02), large tumor volume at referral (P < 0.001), presence of one or more hemodynamic complications (P = 0.02), fast tumor growth velocity (P < 0.001) and high tumor grade (highest tumor grade ≥ 3) (P = 0.049) were associated with poor perinatal outcome on univariate analysis. On stepwise logistic regression analysis, tumor growth velocity was the only remaining independent factor associated with poor perinatal outcome (odds ratio (OR) (per 1-mm/week increase), 1.48 (95% CI, 1.22-1.97), P = 0.001). The best predictive cut-off of tumor growth velocity for poor perinatal outcome was 7 mm/week (OR, 25.7 (95% CI, 5.6-191.3), P < 0.001), yielding a sensitivity of 88% and a specificity of 77%. CONCLUSIONS: Approximately 30% of fetuses with a diagnosis of isolated SCT have poor perinatal outcome. Tumor growth velocity ≥ 7 mm/week appears to be an appropriate discriminative cut-off for poor perinatal outcome. These results could help to inform prenatal management and counseling of parents with an affected pregnancy. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Vinit N, Benachi A, Rosenblatt J, et al. Growth velocity of fetal sacrococcygeal teratoma as predictor of perinatal morbidity and mortality: multicenter study. Ultrasound Obstet Gynecol. 2024. PMID: 39482803. doi:10.1002/uog.29110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。